Quantcast

Novartis division Sandoz recalls one lot of blood pressure drug


Reuters


Nov 8 (Reuters) - Novartis said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug.

The drug is made by China'sZhejiang Huahai Pharmaceutical Co Ltd. Last month, the European Medicines Agency placed the firm under high supervision after a probable carcinogen was found in its blood pressure drug valsartan.

A review was extended to other 'sartan' medicines, including candesartan, irbesartan, losartan, olmesartan and valsartan, after very low levels of a carcinogen was found in losartan made by Hetero Labs in India.




This article appears in: World Markets , Stocks , Economy , Commodities
Referenced Symbols: NOVN



More from Reuters

Subscribe






See Reuters News











Research Brokers before you trade

Want to trade FX?